(Press-News.org) A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia. By combining neuroimaging data from multiple studies involving more than 8,000 participants, the research team found a specific connectivity pattern of atrophy that was present across different stages and symptoms of schizophrenia — and distinct from brain networks associated with other psychiatric disorders. The findings will help to guide a clinical trial that will start recruiting patients soon and will assess brain stimulation sites connected to the schizophrenia network. Results are published in Nature Mental Health.
“We looked for common threads among reports on how schizophrenia affects the brain,” said corresponding author Ahmed T. Makhlouf, MD, of the Center for Brain Circuit Therapeutics and medical director of the Brigham and Women’s Hospital Psychosis Program. “We found that there's atrophy in places all over the brain, but they're all connected to a single network.”
Despite large-scale efforts to resolve the neuroanatomy of schizophrenia, varied results and methodological differences have limited experts’ understanding of circuits linked to brain atrophy.
“One explanation could be that everyone’s actually looking at the same thing from a different vantage point. If multiple people try to feel different parts of an elephant with their eyes closed, they’re going to describe different things,” said senior author Shan H. Siddiqi, MD, a psychiatrist at the Brigham’s Center for Brain Circuit Therapeutics. “Our approach with this study was to try to reconstruct the elephant.”
The research examined data from 90 studies involving atrophy in schizophrenia. The dataset included 1,636 patients with recently diagnosed schizophrenia, 2,120 individuals with chronic disease and just over 6,000 healthy people. The study also examined results from 927 individuals and 580 individuals with genetic or clinical (based on early symptoms) high risk of developing schizophrenia, respectively.
First, the investigators constructed a common brain map combining the widespread locations of atrophy in schizophrenia. Then, they used a technique known as coordinate network mapping (CNM) to estimate the overlap between atrophy locations and functional brain networks. The resulting atrophy connectivity map overlapped with schizophrenia-associated brain regions, including the bilateral insula, hippocampus and fusiform cortex. Finally, the researchers showed that these maps differed from brain connectivity maps developed for aging patients or those with conditions like Alzheimer’s disease, major depressive disorder or substance use disorders — indicating the network was specific to schizophrenia.
The researchers found that the network was similar across patients with contrasting symptoms or at different stages of schizophrenia and did not significantly change with antipsychotic treatments. Patients at high risk of developing schizophrenia shared similarities in atrophy, but there was a unique connectivity pattern in patients who had progressed to clinical disease. The authors suggest that further understanding of atrophy patterns in high-risk individuals could help predict likelihood of developing schizophrenia. The researchers note that future studies with patient-specific connectomes could provide individualized insights. They also note that a clinical trial is planned that will use transcranial magnetic stimulation to assess connectivity of stimulation sites to the identified schizophrenia network.
“There is a debate in the field as to whether or not schizophrenia is a neurodegenerative disorder,” said Makhlouf. “Our study indicates that there is a unique and unified network that might be a core characteristic of schizophrenia.”
Authorship: In addition to Makhlouf and Siddiqi, Mass General Brigham authors include William Drew, Jacob L. Stubbs, Joseph J. Taylor, David Silbersweig, Michael D. Fox. Additional authors include Donato Liloia and Jordan Grafman.
Disclosures: Siddiqi holds intellectual property related to using individualized resting-state network mapping for targeting TMS, filed in 2016, which has not generated royalties and is unrelated to this work. Siddiqi also serves as a scientific consultant for Magnus Medical, has received investigatorinitiated research funding from Neuronetics (2019) and Brainsway (2022), received speaking fees from Brainsway (2021) and Otsuka (for PsychU.org, 2021), and holds shares in Brainsway (publicly traded) and Magnus Medical (privately held). Fox is a scientific consultant for Magnus Medical and owns separate intellectual property related to using functional connectivity to target TMS for depression, filed in 2013, which has not generated royalties and is unrelated to this work
Funding: Harvard Medical School (Dupont Warren Fellowship Award, Livingston Award), the NIH (grant no. R01MH113929, K23MH129829, R01MH113929, R21MH126271, R56AG069086, R01MH115949, R01AG060987, K23MH121657, R21MH126271, R01MH136248), Canadian Institutes of Health Research Vanier Scholarship and a University of British Columbia Friedman Award for Scholars in Health, Brain and Behavior Research Foundation Young Investigator Grant (no. 31081), Sidney R. Baer, Jr. Foundation, Baszucki Brain Research Fund, the Nancy Lurie Marks Foundation, the Kaye Family Research Endowment, the Baszucki Brain Research Fund, the Brain and Behavior Research Foundation Young Investigator Grant, and the Baszucki Brain Research Fund and the Department of Veterans Affairs (grant no.I01CX002293).
Paper cited: Makhlouf AT et al. “Heterogenous Patterns of Brain Atrophy in Schizophrenia Localize to A Common Brain Network”Nature Mental Health DOI: 10.1038/s44220-024-00348-5
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Research has long shown that humans are susceptible to “social identity bias”—favoring their group, whether that be a political party, a religion, or an ethnicity, and disparaging “outgroups.” A new study by a team of scientists finds that AI systems are also prone to the same type of biases, revealing fundamental group prejudices that reach beyond those tied to gender, race, or religion.
“Artificial Intelligence systems like ChatGPT can develop ‘us versus them’ biases similar to humans—showing favoritism toward their perceived ‘ingroup’ while expressing ...
It has been known for nearly 20 years that slow, synchronous electrical waves in the brain during deep sleep support the formation of memories. Why that is was previously unknown. Now, writing in the journal Nature Communications, a team of researchers from Charité – Universitätsmedizin Berlin posits an explanation. According to the study, the slow waves make the neocortex, the location of long-term memory, especially receptive to information. The findings could help to optimize the treatment approaches that are intended to support memory formation from outside.
How do permanent memories form? Experts believe that while we sleep, our brains replay the events of ...
Railways, the most climate-friendly mode of transport bar long-distance buses, are bound to play an important role in the fight for net zero. The total emissions of railway travel are currently 31 grams of CO2 equivalents (CO2e) per passenger kilometer, half the amount as for the most economical electrical vehicles.
But the carbon emissions of railway traffic can be further reduced, shows a new study in Frontiers in Sustainability by authors in Finland. This is because typical construction materials such as steel and concrete are energetically costly to produce, transport, handle, and maintain. Even on the ...
Food poisoning is a common, yet unpleasant, illness caused by eating contaminated items. It is sometimes caused by Clostridium perfringens, a pathogen widely found in soil and the intestinal tracts of animals.
The pathogen multiplies in environments with little oxygen, for example, curry stored in a pot. After ingestion of the pathogen, they form spores in the small intestinal tracts. The toxins produced during spore formation cause diarrhea and abdominal pain, but the underlying mechanism of spore formation has not been fully understood.
Associate Professor Mayo Yasugi’s team at Osaka Metropolitan University’s ...
A new study from Karolinska Institutet shows that long-term exposure to air pollution contributes to millions of deaths in India. The research, published in The Lancet Planetary Health, emphasises the need for stricter air quality regulations in the country.
Air pollution consisting of particles smaller than 2.5 micrometres in diameter, PM2.5, can enter the lungs and bloodstream and is a major health risk in India. Researchers have now examined the link between these particles and mortality over a ten-year ...
Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, finds a study published by The BMJ today.
The researchers say vaccine uptake was below the World Health Organization’s recommended 95% target for all vaccinations studied and call for urgent action to strengthen systems for childhood vaccination.
Protecting children from vaccine preventable diseases ...
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), manufactured by AstraZeneca.
Peter Doshi, senior editor at The BMJ, reveals new details that show problems in data reporting after obtaining primary PLATO trial records and unpublished data through a freedom of information request.
The PLATO trial was published in the New England Journal of Medicine (NEJM) in 2009. Assessing over 18,000 patients in 43 countries, investigators reported that ticagrelor ...
A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that can result from treatment, according to researchers in Cambridge. The findings could lead to the national guidance on chemotherapy treatment for these patients being revised.
The study, published today in The Lancet Oncology was led by Cambridge University Hospitals NHS Foundation Trust (CUH) and the Wellcome Sanger Institute. It compares the lasting effects of two chemotherapy regimens used to treat Hodgkin lymphoma in younger adults. Hodgkin lymphoma ...
ATLANTA, December 11, 2024 — A new study led by American Cancer Society (ACS) researchers shows that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older. The research is published today in the journal The Lancet Oncology.
“The ...
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, DECEMBER 11, 2024
MINNEAPOLIS – Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the December 11, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.
The study does not prove that fluctuations in blood pressure cause problems with thinking skills; it only shows an association.
“These results suggest ...
